Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
The opportunity is conditional: Datacenter and AI must outgrow Client Computing, while better mix and lower capital intensity must turn revenue into cash without heavy dilution.
FY2027 revenue falls below $58.67 billion within 18 months.
Sell: at $104.47 on 2026-09-08, Intel stood above $73.41 Fair value and $88.91 Potential value.2
The main risk is a sustained revenue miss. The top three customers represented 43% of FY2025 revenue, so lost volume or repricing could reduce utilization, margins and cash.4
The clearest upside path requires Datacenter and AI to outgrow Client Computing. Better mix must lift margins, while lower capital intensity leaves more operating cash after investment spending and limits reliance on new shares.23
Demand improves if FY2026 and FY2027 revenue estimates hold and Datacenter and AI grows faster than Client Computing.14
Sell because the report-date price already exceeds Potential value while the recovery still depends on unproven cash generation.2
The bull cycle requires the FY2027 revenue estimate to hold. Faster Datacenter and AI growth than Client Computing is an upside condition, not a reported outcome.1
Sell because the report-date price already exceeds Potential value while the recovery still depends on unproven cash generation.2
INTEL CORP sells its products primarily to OEMs, ODMs and CSPs. ODMs provide design and manufacturing services to branded and unbranded private-label resellers. ▪Segment revenue: consists of revenues from external customers.
Its MD&A begins with an overview of significant events and key developments in 2025 that meaningfully impacted its financial results and/or business. INTEL CORP then provides a detailed discussion of its operating segment results, followed by its consolidated results of operations and other required disclosures for 2025, 2024 and 2023.
The most damaging path combines a persistent revenue miss with customer concentration. Lower utilization then compresses margins while continued investment and dilution reduce cash and value per share.
Intel has large Client Computing and Datacenter and AI businesses, but scale alone does not prove switching costs, software lock-in or a lasting cost advantage.
The selected companies provide a mixed cross-check because their growth, margins and valuation measures vary widely. They should not be treated as interchangeable businesses.
FY2025 GAAP net income was negative $267 million, so FY2025 profitability cannot support a claim of durable excess returns.3
None of the valuation methods used to calculate Fair value relies on a separate assumption about how long the competitive advantage lasts.
The highlighted cell is Fair value when every assumption sits at its base level ($73.41). Each row and column shows what Fair value becomes when one assumption moves.
A free-cash-flow drop test is not available in this run; use the discount-rate and terminal-growth grid as the primary valuation pressure test.
A single beat is insufficient unless segment margins, free cash flow and diluted shares improve together.
FY2025 capex was $14.65 billion, while the industry benchmarks were 4.4% of revenue and 1.27 times depreciation as of 2026-09-01.3
The bull cycle requires the FY2027 revenue estimate to hold. Faster Datacenter and AI growth than Client Computing is an upside condition, not a reported outcome.
The bear cycle is demand-led: concentrated customers can amplify a sales miss through weaker factory use, which would pressure margins.
No new allocation while the Sell rating applies and the report-date price exceeds Potential value.. Reduce existing exposure while the report-date price remains above Potential value. Reconsider only after revenue, margins, free cash flow and diluted shares improve together.2
Do not average down on price alone. Use the stated revenue, capital-spending and profit-to-cash thresholds to reduce or exit exposure.
The $104.47 report-date price exceeds both $73.41 Fair value and $88.91 Potential value.2
The recovery remains conditional on segment growth, margin improvement, lower capital intensity and stable diluted shares.234
Customer concentration can turn a revenue miss into lower utilization, weaker margins and poorer cash generation.
Sell because the report-date price stands above Potential value despite unresolved revenue duration, capital intensity and dilution risks.2
Near-term estimates support a plausible operating recovery, but they do not justify the price without sustained margin and free-cash-flow evidence after FY2027.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
This path would be confirmed by weaker revenue, utilization and cash generation through FY2028. It would be disconfirmed by customer diversification and sustained positive free cash flow.
A customer loss or broad demand miss pushes FY2027 revenue below $58.67 billion, reducing sales, utilization and operating leverage for longer than one period.
Capex remains above 1.5 times depreciation through FY2028, absorbing cash and delaying the point when operating improvement produces distributable free cash flow.
In the next profitable fiscal year, operating cash stays below $0.80 for each $1.00 of profit, weakening the credibility of normalized earnings.
The five developments that would weaken our investment case.
A sustained revenue shortfall would reduce factory utilization, compress operating margins and weaken the recovery path used to support value.
Current:Analyst mean of $71.41 billion for FY2027, available and retrieved on 2026-09-09.
Alert ifBelow $58.67 billion within 18 months.
Persistent excess investment would absorb operating cash, delay positive free cash flow and make the recovery more dependent on outside capital.
Current:Approximately 1.25 times in the investment phase, with FY2025 capex of $14.65 billion.
Alert ifAbove 1.5 times through FY2028.
Customer loss or repricing would cut sales and utilization together, causing a larger decline in gross margin, earnings and free cash flow.
Current:43% of FY2025 revenue.
Alert ifA named customer cuts volume, reprices purchases or moves production before FY2027.
Continued issuance would spread any profit and free cash flow across more shares, reducing the per-share benefit of an operating recovery.
Current:5.286 billion outstanding on 2026-09-09 versus a 4.530 billion FY2025 diluted average.
Alert ifShares continue rising through two fiscal years while free cash flow remains negative.
Sustained relative weakness would indicate continuing share or pricing pressure, limiting revenue duration and the operating margin achievable from higher factory utilization.
Current:Selected peers showed widely different revenue growth and operating margins as of 2026-09-09.
Alert ifBelow the selected-peer median growth percentile and below a 15% operating margin for two consecutive fiscal years.
| Threat | Severity | Timeline | Mitigation |
|---|
| Faster-growing semiconductor peers can pressure share, pricing and factory utilization. | high | Two consecutive fiscal years | Compare Intel's revenue growth and operating margin with the selected companies over two consecutive fiscal years. Sustained improvement in both measures would weaken this competitive concern. |
| Large customers can use purchasing power to seek lower prices or move volume. | high | Next annual filing | Use 35% as a decision threshold, not a reported benchmark. A sustained move below it without lost consolidated revenue would show that reliance on the three largest customers has materially declined.4 |
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Project revenue, apply a terminal EV/revenue multiple, discount enterprise value, subtract net debt, and divide by diluted shares.
Solve for the growth rate that makes the model value equal the report-date share price.
Evidence should arrive by FY2027 through reported revenue, segment growth and margin improvement. The path weakens if FY2027 revenue misses the estimate or Datacenter and AI does not improve the mix.1
The next reported share count is the test. Stability supports this path; an increase would spread any operating recovery across more shares and weaken per-share results.23
Meeting estimates preserves the recovery thesis but does not prove long-run margins or free-cash-flow conversion.
A broad miss would weaken utilization, margins and the revenue recovery supporting Fair value.
FY2025 reported a GAAP net loss, while the FY2027 analyst-consensus EPS forecast uses an adjusted basis and is not directly comparable. The report-date period-end share count exceeded FY2025 diluted weighted-average shares, but the measures use different bases. In the next profitable fiscal year, reported profit must produce operating cash, while like-for-like diluted shares must stabilize.123
Lower excess spending would allow operating cash to become free cash flow.3
Lower reliance on major buyers would reduce volume, repricing and utilization risk.4
Continued issuance would reduce earnings and free cash flow attributable to each share.2
| $79.02B |
| $63.05B |
| $54.23B |
| $53.10B |
| $52.85B |
| -9.6% |
| Gross profit | $43.82B | $26.87B | $21.71B | $17.35B | $18.38B | -19.5% |
| Operating income | $19.46B | $2.33B | $93.0M | $-11.68B | $-2.21B | — |
| Net income | $19.87B | $8.01B | $1.69B | $-18.76B | $-267.0M | — |
| EPS (diluted) | $4.86 | $1.94 | $0.40 | $-4.38 | $-0.06 | — |
| EBITDA | $36.50B | $15.37B | $93.0M | $1.20B | $14.35B | -20.8% |
| R&D | $15.19B | $17.53B | $16.05B | $16.55B | $13.77B | -2.4% |
| SG&A | $6.54B | $7.00B | $5.63B | $5.51B | $4.62B | -8.3% |
Capex fell from $25.75 billion in FY2023 to $14.65 billion in FY2025, but remained a large cash claim. Further decline must not impair revenue growth.3
Priority should remain on funding productive assets while limiting new debt and dilution. Evidence of success is stable shares, lower net debt and sustained positive free cash flow.
FY2025 remained loss-making while capital spending stayed substantial, so a durable return recovery is not yet demonstrated.
A period-matched return-on-invested-capital comparison is not established by the cited evidence.
FY2025 GAAP net income was negative $267 million on $52.85 billion of revenue.
The valuation depends on recovery rather than established earnings power.
Outstanding shares were 5.286 billion on 2026-09-09 versus a 4.530 billion FY2025 diluted average.
More shares reduce the per-share benefit of future profit and cash growth.
Total debt was $50.54 billion on 2026-09-09.
Continued cash demands can limit financial flexibility.
| Revenue | $52,853,000,000 |
|---|---|
| Cost of revenue | $34,478,000,000 |
| Gross profit | $18,375,000,000 |
| Operating expenses | $20,589,000,000 |
| Operating income | -$2,214,000,000 |
| Non-operating items and tax | $1,947,000,000 |
| Net income | -$267,000,000 |
| Total assets | $211,429,000,000 |
|---|---|
| Cash | $14,265,000,000 |
| Current assets | $63,688,000,000 |
| Total liabilities | $85,069,000,000 |
| Current liabilities | $31,575,000,000 |
| Shareholders’ equity | $126,360,000,000 |
| Net income | $1,689,000,000 |
|---|---|
| Operating inflow | $14,520,000,000 |
| Depreciation and amortization | $9,602,000,000 |
| Stock-based compensation | $3,229,000,000 |
| Operating cash flow | $11,471,000,000 |
| Operating outflow | $3,049,000,000 |
| Cash available | $31,120,000,000 |
| Beginning cash | $11,144,000,000 |
| Financing inflow | $8,505,000,000 |
| Investing outflow | $24,041,000,000 |
| Ending cash | $7,079,000,000 |
| Investing cash flow | -$24,041,000,000 |
| Financing cash flow | $8,505,000,000 |
Source: SEC EDGAR · Filed 2026-01-23 · SEC EDGAR
| Revenue by operating segment | Revenue | Share | YoY |
|---|---|---|---|
| Client Computing Group | $32.2B | 61% | -3.4% |
| Datacenter And AI | $16.9B | 32% | 4.9% |
| All Other Segments | $3.6B | 6.7% | -1.1% |
Source: SEC EDGAR · Filed 2026-01-23 · SEC EDGAR
| Revenue by geography | Revenue | Share | YoY |
|---|---|---|---|
| United States | $15.8B | 29.8% | 21.3% |
| China Including Hong Kong | $12.7B | 24% | -18.3% |
| Singapore | $9.5B | 18% | -6.4% |
| Taiwan | $7.7B | 14.5% | -1.7% |
| Other | $7.2B | 13.6% | 9.3% |
Point-in-time financial data used in the 2026-09-09 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $59.4B | $13.2B | $10.3B | $21.8B | $12.2B | $9.6B | $294M | $1.4B | $2.6B | $4.9B | — | -$25.8B | -$5.7B | — | $5.6B | $17.1B | $25.3B | 22.1% | — | — | — |
| 2017-12-30 | $62.8B | $18.1B | $9.6B | $22.1B | $10.3B | $11.8B | $177M | $1.4B | $3.6B | $5.1B | — | -$15.8B | -$8.5B | $5.6B | $3.4B | $14B | $26.8B | 28.8% | — | — | — |
| 2018-12-29 | $70.8B | $23.5B | $21.1B | $29.4B | $14.3B | $15.2B | $200M | $1.5B | $10.7B | $5.5B | — | -$11.2B | -$18.6B | $3.4B | $3B | $11.7B | $25.9B | 32.9% | — | — | — |
| 2019-12-28 | $72B | $33.6B | $21B | $33.1B | $16.9B | $16.2B | $200M | $1.7B | $13.6B | $5.6B | — | -$14.4B | -$17.6B | $3B | $4.2B | $13.1B | $29B | 30.6% | — | — | — |
| 2020-12-26 | $77.9B | $38B | $20.9B | $35.9B | $21.6B | $14.3B | $12.2B | $1.9B | $14.2B | $5.6B | — | -$21.5B | -$12.7B | $4.2B | $5.9B | $23.9B | $36.4B | 30.4% | — | — | — |
| 2021-12-25 | $79B | $36.5B | $19.9B | $29.5B | $10.7B | $18.7B | $11.8B | $2B | $2.4B | $5.6B | — | -$24.3B | -$6.2B | $5.9B | $4.8B | $28.4B | $38.1B | 24.6% | — | 7.6% | — |
| 2022-12-31 | $63.1B | $15.4B | $8B | $15.4B | -$9.4B | $24.8B | $13B | $3.1B | $0 | $6B | $5.5B | -$10.2B | $1.1B | $4.8B | $11.1B | $28.3B | $38.1B | 3.7% | — | 9.4% | — |
| 2023-12-30 | $54.2B | $93M | $1.7B | $11.5B | -$14.3B | $25.8B | $9.6B | $3.2B | $0 | $3.1B | $7B | -$24B | $8.5B | $11.1B | $7.1B | $25B | $49.3B | 0.2% | — | 11.0% | — |
| 2024-12-28 | $53.1B | $1.2B | -$18.8B | $8.3B | -$15.7B | $23.9B | $11.4B | $3.4B | — | $1.6B | $687M | -$18.3B | $11.1B | $7.1B | $8.2B | $22.1B | $50B | -22.0% | — | — | — |
| 2025-12-27 | $52.9B | $14.4B | -$267M | $9.7B | -$4.9B | $14.6B | $11.7B | $2.4B | — | $0 | -$3.8B | -$14.8B | $11.6B | $8.2B | $14.7B | $37.4B | $46.6B | -4.2% | — | — | — |
Intel Corporation (INTC) trades at 51.8x forward earnings against a peer median of 33.1x. Its EV/EBITDA of 33.5x compares with a peer median of 69.8x. The comparison uses 4 peers: Advanced Micro Devices Inc., Micron Technology Inc., CrowdStrike Holdings Inc. and Marvell Technology Inc., as of 2026-09-08 to 2026-09-09.
| Impact |
|---|
| Note |
|---|
| Datacenter and AI mix | positive | The segment produced $16.92 billion in FY2025, giving Intel a material growth lever if it outpaces Client Computing. |
Disclosed FY2025 geographic revenue included $12.69 billion from China including Hong Kong, $9.54 billion from Singapore and $7.67 billion from Taiwan. The United States was the largest disclosed geography at $15.76 billion.4
| Action |
|---|
| Why |
|---|
| Above $88.91 Potential value | Do not initiate or add exposure while the Sell rating applies and the report-date price remains above Potential value. | The price would remain above the accepted public valuation range. |
| At or below $73.41 Fair value | Reassess the Sell stance, but do not buy on price alone; the report-date price was above Potential value. | Require sustained positive free cash flow, stable diluted shares and segment-margin improvement. |
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
| $11.98B |
| $13.57B |
| $14.65B |
| $15.53B |
| $16.31B |
| $17.04B |
| $17.72B |
| $18.34B |
| $18.94B |
| $19.51B |
| NOPAT | $9.46B | $10.72B | $11.57B | $12.27B | $12.88B | $13.46B | $14.00B | $14.49B | $14.96B | $15.41B |
| Residual cash after reinvestment policy | $9.46B | $10.72B | $11.57B | $12.27B | $12.88B | $13.46B | $14.00B | $14.49B | $14.96B | $15.41B |
| Revenue growth | 19.3% | 13.3% | 8.0% | 6.0% | 5.0% | 4.5% | 4.0% | 3.5% | 3.3% | 3.0% |
| Operating margin | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% | 19.0% |
| Tax rate | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% | 21.0% |
| Reinvestment rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Terminal growth | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| Micron Technology Inc. |
| 6.5x |
| 12.5x |
| 16.3x |
| 66.6% |
| 80.4% |
| CRWD | CrowdStrike Holdings Inc. | 130.9x | 39.9x | 1.5% | -2.3% |
| MRVL | Marvell Technology Inc. | 33.5x | 21.4x | 69.8x | 16.5% | 16.7% |
